Dai WF, Beca J, Croxford R, Isaranuwatchai W, et al. Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada. Int J Cancer 2020 Oct 26. doi: 10.1002/ijc.33357.
PMID: 33105030